Cargando…

Treating Postpartum Depression: What Do We Know about Brexanolone?

Postpartum depression (PPD) is defined as the onset of major depressive disorder in mothers, occurring during pregnancy or within 4 weeks post-delivery. With 7% of pregnancy-related death in the United States owing to mental health conditions, including PPD, and a global prevalence of 12%, PPD is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Muneeza, Aamir, Alifiya, Diwan, Mufaddal Najmuddin, Awan, Hashir Ali, Ullah, Irfan, Irfan, Muhammad, De Berardis, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293057/ https://www.ncbi.nlm.nih.gov/pubmed/34287271 http://dx.doi.org/10.3390/diseases9030052

Ejemplares similares

SARS-CoV-2 and the Brain: What Do We Know about the Causality of ‘Cognitive COVID?
por: Ali Awan, Hashir, et al.
Publicado: (2021)

Effect of COVID-19 on Mental Health Rehabilitation Centers
por: Aamir, Alifiya, et al.
Publicado: (2020)

Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
por: Ullah, Irfan, et al.
Publicado: (2021)

Internet and Pornography Use During the COVID-19 Pandemic: Presumed Impact and What Can Be Done
por: Awan, Hashir Ali, et al.
Publicado: (2021)

Suicide in Healthcare Workers: Determinants, Challenges, and the Impact of COVID-19
por: Awan, Sana, et al.
Publicado: (2022)

Measles Induced Encephalitis: Recent Interventions to Overcome the Obstacles Encountered in the Management Amidst the COVID-19 Pandemic
por: Diwan, Mufaddal Najmuddin, et al.
Publicado: (2022)

Efficacy of brexanolone in postpartum depression
por: Rodríguez Mercado, C. M.
Publicado: (2023)

Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’
por: Shukla, Ajay Kumar, et al.
Publicado: (2021)

Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
por: Garafola, Svetlana, et al.
Publicado: (2023)

Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review
por: Ullah, Irfan, et al.
Publicado: (2021)

Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression
por: Kanes, Stephen J., et al.
Publicado: (2017)

Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?
por: Faden, Justin, et al.
Publicado: (2020)

Patient-reported perceptions of brexanolone in the treatment of postpartum depression: A qualitative analysis
por: Salwan, Aaron, et al.
Publicado: (2023)

Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making
por: Gerbasi, Margaret E., et al.
Publicado: (2021)

Brexanolone, a GABA(A) Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review
por: Edinoff, Amber N., et al.
Publicado: (2021)

Postpartum Depression and Health: Role of Perceived Social Support among Pakistani Women
por: Jamshaid, Samrah, et al.
Publicado: (2023)

What do we know about neutrinos?
por: Vannucci, François
Publicado: (1994)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States
por: Eldar-Lissai, Adi, et al.
Publicado: (2020)

Cholera outbreak in Balochistan amidst flash floods: an impending public health crisis
por: Jawed, Shizra, et al.
Publicado: (2023)

What We Know and Do Not Know about Sex and Cardiac Disease
por: Konhilas, John P.
Publicado: (2010)

Q&A: What do we know about influenza and what can we do about it?
por: Doherty, Peter C, et al.
Publicado: (2009)

What do we know about the Higgs boson ?
por: Gambino, Paulo
Publicado: (2002)

What do We Know about Neonatal Cognition?
por: Streri, Arlette, et al.
Publicado: (2013)

What Do We Know about Opioids and the Kidney?
por: Mallappallil, Mary, et al.
Publicado: (2017)

What do we know about Tietze’s syndrome?
por: Rokicki, Wojciech, et al.
Publicado: (2018)

What Do We Know about Nociplastic Pain?
por: Bułdyś, Kacper, et al.
Publicado: (2023)

Transcranial Electrical Stimulation: What We Know and Do Not Know About Mechanisms
por: Fertonani, Anna, et al.
Publicado: (2016)

Brexanolone as adjunctive therapy in super‐refractory status epilepticus
por: Rosenthal, Eric S., et al.
Publicado: (2017)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Do we know enough about human immunodeficiency virus and COVID-19 coinfection?
por: Alabbadi, Ali M., et al.
Publicado: (2020)

What Do We Know About Neuropsychological Aspects Of Schizophrenia?
por: Palmer, Barton W., et al.
Publicado: (2009)

What do we know about $\sigma$?: summary of the session
por: Montanet, Lucien
Publicado: (1999)

What Do We Really Know About Neutron Stars?
por: Woltjer, Lodewijk
Publicado: (2003)

Fungal Melanin: What do We Know About Structure?
por: Nosanchuk, Joshua D., et al.
Publicado: (2015)

What we do not know about cerebellar systems neuroscience
por: Voogd, Jan
Publicado: (2014)

Targeting Microbiota: What Do We Know about It at Present?
por: Derovs, Aleksejs, et al.
Publicado: (2019)

What do we know about pediatric renal microlithiasis?
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2016)

What Do We Know About Remdesivir Drug Interactions?
por: Yang, Katherine
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hldfd579f9qdkp0s1198va6vqa